SCHEMBL3607401

SCHEMBL3607401

COc1ccc(COc2cc(Oc3c(/C=C/C(=O)O)c(C)nn3C)c(Cl)cc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
KDM4E B2RXH2 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC8 Q9BY41 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CASP3 P42574 1/20 0.38
KMT2A Q03164 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER2 P43116 1/20 0.38
GAA P10253 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.37
CA2 P00918 1/20 0.37
CA5A P35218 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3607405 1.00 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3612420 0.87 SMN1; SMN2 (0.53) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3604681 0.85 SMN1; SMN2 (0.40) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3603282 0.84 GAA (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3603279 0.84 GAA (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3613236 0.84 KDM4E (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3605154 0.83 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3605148 0.83 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL3610486 0.83 PTGDR2 (0.49) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E
Hydrochloric Acid SCHEMBL3614835 0.82 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885CYP1A2 137/4885CYP2C9 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.